PS155. Long-term safety of adjunctive brexpiprazole (OPC-34712) in MDD: results from two 52-week open-label studies

Craig Nelson, Aleksandar Skuban, Peter Zhang, Emmanuelle Weiller, Catherine WeissThe International Journal of Neuropsychopharmacology 2016 · DOI

BibTeX
@article{nelson2016ps,
  author = {Craig Nelson and Aleksandar Skuban and Peter Zhang and Emmanuelle Weiller and Catherine Weiss},
  title = {{PS155. Long-term safety of adjunctive brexpiprazole (OPC-34712) in MDD: results from two 52-week open-label studies}},
  journal = {The International Journal of Neuropsychopharmacology},
  year = {2016},
  doi = {10.1093/ijnp/pyw043.155},
}

Loading related content...

Figure